Combination With News Today

Sales Reflect Continued Strong Growth in Oncology and Vaccines Total Worldwide Sales Were $15.8 Billion, an Increase of 9% From First Quarter 2023; Excluding the Impact of Foreign Exchange,...

The approval was based on the QUILT-3.032 study, which included 77 adults with carcinoma in situ with or without papillary tumors after a transurethral resection.

A single subcutaneous injection of the investigational drug zilebesiran, when added to existing treatment with a standard antihypertensive medication,....

Hi there, Tomorrow begins the ACC 73rd Annual Scientific Sessions in Atlanta. Experts from the University of Michigan Health Frankel Cardiovascular Center have

Hi there, Tomorrow begins the ACC 73rd Annual Scientific Sessions in Atlanta. Experts from the University of Michigan Health Frankel Cardiovascular Center have

Fourth-Quarter and Full-Year Sales Reflect Sustained Growth Across Oncology and Vaccines Fourth-Quarter Worldwide Sales Were $14.6 Billion, an Increase of 6% From Fourth Quarter 2022; Excluding...

Gilead Sciences Kurs heute • Aktuelle Realtime Finanzdaten, Nachrichten und Informationen zur Aktie (GILD) • US3755581036 (885823) • Chemie • Pharma

Discover the best creatine supplements to boost your workouts and promote muscle growth. Read expert reviews, recommendations, and research you can trust.

BOSTON - Vertex Pharmaceuticals Incorporated today announced that the European Commission has granted approval for the label expansion of KAFTRIO in a combination regimen with ivacaftor for the...

 -Application to add ~200 non-F508del CFTR mutations to the KAFTRIO® license- -If approved, ~2,800 people with cystic fibrosis in the European Union ages 2 and above could receive a medicine that...